Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials

Overview of attention for article published in Drug Design, Development and Therapy, February 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 6 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Multinational Association of Supportive Care in Cancer - MASCC, 08 Mar 2018

Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination…